Evidence map›Paper›PMID 22349815›Full record

ArticleOncogene2012

Cyclin E drives human keratinocyte growth into differentiation.

A Freije, L Ceballos, M Coisy, L Barnes, M Rosa, E De Diego, J M Blanchard, A Gandarillas

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Effects of 445 nm, 520 nm, and 638 nm Laser Irradiation on the Dermal Cells.International journal of molecular sciences · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Polyploidy and the mitosis path to epidermal cell fate.Cell cycle (Georgetown, Tex.) · 2019
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

A FreijeCell Cycle, Stem Cell Fate and Cancer Laboratory, Institute for Training and Research of the Fundación Marqués de Valdecilla (IFIMAV-FMDV), Santander, Spain.
L Ceballos
M Coisy
L Barnes
M Rosa
E De Diego
J M Blanchard
A Gandarillas
Fundación Marques de Valdecilla · ESCentre National de la Recherche Scientifique · FRInserm · FRInstitut de Génétique Moléculaire de Montpellier · FRMarqués de Valdecilla University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human epidermis is continuously exposed to environmental mutagenic hazard and is the most frequent target of human cancer. How the epidermis coordinates proliferation with differentiation to maintain homeostasis, even in hyperproliferative conditions, is unclear. For instance, overactivation of the proto-oncogene MYC in keratinocytes stimulates differentiation. Here we explore the cell cycle regulation as proliferating human keratinocytes commit to terminal differentiation upon loss of anchorage or overactivation of MYC. The S-phase of the cell cycle is deregulated as mitotic regulators are inhibited in the onset of differentiation. Experimental inhibition of mitotic kinase cdk1 or kinases of the mitosis spindle checkpoint Aurora B or Polo-like Kinase, triggered keratinocyte terminal differentiation. Furthermore, hyperactivation of the cell cycle by overexpressing the DNA replication regulator Cyclin E induced mitosis failure and differentiation. Inhibition of Cyclin E by shRNAs attenuated the induction of differentiation by MYC. In addition, we present evidence that Cyclin E induces DNA damage and the p53 pathway. The results provide novel clues for the mechanisms committing proliferative keratinocytes to differentiate, with implications for tissue homeostasis maintenance, HPV amplification and tumorigenesis.

Indexed as

Aurora Kinase BAurora KinasesCDC2 Protein KinaseCell Cycle ProteinsCell DifferentiationCell ProliferationCells, CulturedCyclin EDNA DamageDNA ReplicationEpidermal CellsEpidermisHumansKeratinocytesMitosisPolo-Like Kinase 1AURKB protein, humanAurora Kinase BAurora KinasesCDC2 Protein KinaseCell Cycle ProteinsCyclin EMAS1 protein, humanPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene MasProto-Oncogene ProteinsProto-Oncogene Proteins c-mycTumor Suppressor Protein p53

Identifiers

PMID22349815
OpenAlexW2012126342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.